NCT03694925View on ClinicalTrials.gov

Diagnostic Utility of a Novel Point-of-Care Test of Calprotectin for Revision Total Knee Arthroplasty

CompletedOBSERVATIONAL
Enrollment

156

Participants

Timeline

Start Date

October 29, 2018

Primary Completion Date

January 7, 2020

Study Completion Date

March 4, 2020

Conditions
Prosthetic Joint Infection
Interventions
DIAGNOSTIC_TEST

Calprotectin test

Calprotectin will be measured both by ELISA and point of care test.

Trial Locations (2)

33331

Cleveland Clinic Florida, Weston

44195

Cleveland Clinic, Cleveland

All Listed Sponsors
lead

The Cleveland Clinic

OTHER

NCT03694925 - Diagnostic Utility of a Novel Point-of-Care Test of Calprotectin for Revision Total Knee Arthroplasty | Biotech Hunter | Biotech Hunter